Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.
Wang S, Rong R, Yang DM, Fujimoto J, Bishop JA, Yan S, Cai L, Behrens C, Berry LD, Wilhelm C, Aisner D, Sholl L, Johnson BE, Kwiatkowski DJ, Wistuba II, Bunn PA Jr, Minna J, Xiao G, Kris MG, Xie Y.
Wang S, et al. Among authors: yan s.
J Clin Invest. 2023 Jan 17;133(2):e160330. doi: 10.1172/JCI160330.
J Clin Invest. 2023.
PMID: 36647832
Free PMC article.